Pliant Therapeutics
PLRX
PLRX
134 hedge funds and large institutions have $1.14B invested in Pliant Therapeutics in 2023 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 53 increasing their positions, 34 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 136 → 134 (-2)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
65% less call options, than puts
Call options by funds: $2.06M | Put options by funds: $5.88M
Holders
134
Holding in Top 10
7
Calls
$2.06M
Puts
$5.88M
Top Buyers
| 1 | +$54.4M | |
| 2 | +$13M | |
| 3 | +$11.9M | |
| 4 |
BlackRock
New York
|
+$8.67M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$7.87M |
Top Sellers
| 1 | -$8.71M | |
| 2 | -$6.42M | |
| 3 | -$5.65M | |
| 4 |
VA
VR Adviser
New York
|
-$5.01M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.22M |